BioCentury
ARTICLE | Company News

MacroArray, Abbott deal

March 19, 2007 7:00 AM UTC

ABT received a semi-exclusive license to develop and market MacroArray's prostate cancer-associated diagnostic marker 1 (PCADM1) MAb assay. MacroArray has completed blinded clinical studies using the ...